US.EW · Edwards Lifesciences

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.690865671641791,
        "turnoverUsdM": 470.56051375,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.EW",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 79.2428,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 5.4,
      "take_profit_price": 88.7455,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 6
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.381731343283582,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 52.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 46.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 6
  },
  "market": {
    "ma20": 89.8035,
    "ma50": 87.195,
    "close": 83.75,
    "prevClose": 84.37,
    "avgVolume20": 5051826,
    "volumeRatio": 1.11,
    "changePercent": -0.73
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 6,
    "details": {
      "ret_5d": -0.046561930783242333,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 6,
      "vcp_bonus": 0,
      "vol_ratio": 1.1245184746646741,
      "ret_points": 0,
      "vol_points": 2,
      "range_ratio": 0.6941494805590422,
      "volat_points": 0,
      "day_range_pct": 0.017432835820895616,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 52.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 62,
        "contribution": 3.1
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 7,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 46.67,
        "contribution": 7
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 12.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 41.67,
        "contribution": 12.5
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 46.6,
    "details": [
      "基本面分析總分: 3.1/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 7/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 12.5/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 3.1,
      "資金流": 5.2,
      "市場環境": 7,
      "情緒分析": 6,
      "技術信號": 12.5,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 2,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 470.56051375,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.EW",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.64
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 713.3184992500002,
                "ma50": 718.7466015999998,
                "name": "QQQ",
                "close": 691.91998,
                "points": 0.4
              },
              "spy": {
                "ma20": 745.92100485,
                "ma50": 745.0528012400001,
                "name": "SPY",
                "close": 738.16998,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.690865671641791,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 2,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140998825,
                "url": "https://finnhub.io/api/news?id=7beb6bec9acf77d6f736316b476aa5087289cc1e2a06e562a78ba100f0bb3f45",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "Edwards Lifesciences reported Q2 2026 earnings in line with estimates, posted $0.78 EPS, and raised full-year sales guidance, driving a 6.2% after-hours stock surge.",
                "category": "company",
                "datetime": 1784839844,
                "headline": "Edwards Lifesciences (NYSE:EW) Raises Guidance After Solid Q2 Earnings, Stock Surges 6%"
              },
              {
                "id": 140768835,
                "url": "https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...",
                "category": "company",
                "datetime": 1782778531,
                "headline": "Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"
              }
            ],
            "raw_source": [
              {
                "id": 140999713,
                "url": "https://finnhub.io/api/news?id=3dd0b827f131d78c22045ed45fe4009f4d0efca7d573b08b6179be9aac9bef3f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock launched higher Thursday after the medtech company beat Wall Street's top- and bottom-line expectations.",
                "category": "company",
                "datetime": 1784841288,
                "headline": "Edwards Stock Launches As Heart-Valve Replacements Beat On"
              },
              {
                "id": 140999050,
                "url": "https://finnhub.io/api/news?id=d32847d0307152ac4528851d0189d27c3f79291e50e1560ca3d49c3033173e86",
                "image": "https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.",
                "category": "company",
                "datetime": 1784840701,
                "headline": "Which S&P500 stocks are moving after the closing bell on Thursday?"
              },
              {
                "id": 140998825,
                "url": "https://finnhub.io/api/news?id=7beb6bec9acf77d6f736316b476aa5087289cc1e2a06e562a78ba100f0bb3f45",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "Edwards Lifesciences reported Q2 2026 earnings in line with estimates, posted $0.78 EPS, and raised full-year sales guidance, driving a 6.2% after-hours stock surge.",
                "category": "company",
                "datetime": 1784839844,
                "headline": "Edwards Lifesciences (NYSE:EW) Raises Guidance After Solid Q2 Earnings, Stock Surges 6%"
              },
              {
                "id": 140999714,
                "url": "https://finnhub.io/api/news?id=50971ac8fc6d458186caa23186c6cbb56df2590de183c7a1adbee31c4d5dcc3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IRVINE, Calif., July 23, 2026--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2026.",
                "category": "company",
                "datetime": 1784837700,
                "headline": "Edwards Lifesciences Reports Second Quarter Results"
              },
              {
                "id": 140998874,
                "url": "https://finnhub.io/api/news?id=e5ba571ed4be393c5c05c23003ab3cbe4fbd4d46a5ba91afa3e959186b2a9c40",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) is looking for Q3 Adj EPS of $0.71-$0.77 vs $0.74 analyst estimate. sees sales of $1.630 billion-$1.710 billion vs $1.689 billion analyst estimate.",
                "category": "company",
                "datetime": 1784823417,
                "headline": "Edwards Lifesciences Sees Q3 Adj EPS $0.71-$0.77 vs $0.74 Est; Sees Sales $1.630B-$1.710B vs $1.689B Est"
              },
              {
                "id": 140998875,
                "url": "https://finnhub.io/api/news?id=6ba372496fc63fec1418eb67db9aad66621b71f18f3d37b860fc78d8e6066c85",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) affirms FY2026 Adj EPS guidance from $2.95-$3.05 to $2.95-$3.05 vs $3.01 analyst estimate. Raises FY2026 sales outlook from $6.500 billion-$6.900 billion to $6.600 billion-$6.900 billion",
                "category": "company",
                "datetime": 1784823370,
                "headline": "Edwards Lifesciences Affirms FY2026 Adj EPS Guidance of $2.95-$3.05 vs $3.01 Est; Raises FY2026 Sales Guidance from $6.500B-$6.900B to $6.600B-$6.900B vs $6.745B Est"
              },
              {
                "id": 140998876,
                "url": "https://finnhub.io/api/news?id=84dc80c0a89fee1667f417cd038d00e39479d38e89180a3f811b4886f393cc67",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.74 by 5.41 percent. This is a 16.42 percent increase over earnings of $0.67 per share from",
                "category": "company",
                "datetime": 1784823335,
                "headline": "Edwards Lifesciences Q2 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $1.741B Beat $1.700B Estimate"
              },
              {
                "id": 140996690,
                "url": "https://finnhub.io/api/news?id=85af9e8893acc6773c696c8ffbce2fa38f27f38ee6fd643adf77b9f3130959f1",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1784813736,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 140993809,
                "url": "https://finnhub.io/api/news?id=a47ad7f0bc8a271af3493561d9e532c43ff1705e233807236e6b2cf91a6dc883",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Companies Reporting Before The Bell\n• Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. \n• Dime Commercial (NYSE:DCOM) is expected to report",
                "category": "company",
                "datetime": 1784790711,
                "headline": "Earnings Scheduled For July 23, 2026"
              },
              {
                "id": 140960859,
                "url": "https://finnhub.io/api/news?id=97af80ad8ab4420f78a1207f54a4d08df4680ba053061f1404d83440a6f0dda2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "EW heads into Q2 earnings results with estimates calling for double-digit revenue growth as TAVR, TMTT and Surgical heart businesses remain in focus.",
                "category": "company",
                "datetime": 1784553780,
                "headline": "Edwards' Q2 Earnings on the Horizon: What's in the Cards?"
              },
              {
                "id": 140923844,
                "url": "https://finnhub.io/api/news?id=32da7eb77d4992ff3dda71d86dac896e66f7a630f14de4145a045b2bb87a9692",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Truist Securities  analyst Richard Newitter   maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $90 to $95.",
                "category": "company",
                "datetime": 1784203176,
                "headline": "Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $95"
              },
              {
                "id": 140918806,
                "url": "https://finnhub.io/api/news?id=9ce29e8a103f05ede7f01b3cc8dc6fdfea85964c53b145569e6e0d2ce4bf97e1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IRVINE, Calif., July 16, 2026--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2026 after the market closes on Thursday July 23, and will host a conference call at 5:00 p.m. ET that day to discuss those results.",
                "category": "company",
                "datetime": 1784199900,
                "headline": "Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026"
              },
              {
                "id": 140923845,
                "url": "https://finnhub.io/api/news?id=c1bc6bd2c0bc50ee5f997e20172409d41e1d2a6a2254bcba8ee487a35ae39698",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Mizuho  analyst Anthony Petrone   maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $100 to $105.",
                "category": "company",
                "datetime": 1784125451,
                "headline": "Mizuho Maintains Outperform on Edwards Lifesciences, Raises Price Target to $105"
              },
              {
                "id": 140900008,
                "url": "https://finnhub.io/api/news?id=046fa9e725fbd21c8d4cd5bb04dc474ca78380f1c2a35257e14f172cdc026a53",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The FTC secured the penalty after a court ruled that Edwards failed to comply with antitrust law requirements when it acquired JC Medical in 2024.",
                "category": "company",
                "datetime": 1784046736,
                "headline": "Edwards Lifesciences served $10m penalty over JC Medical acquisition violations"
              },
              {
                "id": 140891355,
                "url": "https://finnhub.io/api/news?id=7a86d3baa26466a4ba265293463d7e0d19d79051b37231f79e80188e97b14440",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "(Bloomberg) -- The Federal Trade Commission urged a judge to block Henkel AG’s $725 million purchase of part of Pittsburgh Paint Co., saying the deal would harm competition in the liquid-adhesive market by combining two of its biggest players.Most Read from BloombergLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Trump Restarts Iran Blockade as US Plans 20% Hormuz ChargeTrump Embraces Australian Retirement System Backed by Larry FinkOpenAI Engineer’s ‘LOL’ Moment Set Stage for Legal Fig",
                "category": "company",
                "datetime": 1783969528,
                "headline": "FTC Says Henkel Deal Would Merge ‘Coke and Pepsi’ of Adhesives"
              },
              {
                "id": 140891424,
                "url": "https://finnhub.io/api/news?id=2583080fb9cb1dc1a1aa6630bcae89cf976a37974a965d1b7dcfe37c7df91053",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to sidestep a Hart-Scott-Rodino review.",
                "category": "company",
                "datetime": 1783962134,
                "headline": "Edwards will pay $10M to settle FTC charges of skirting antitrust review"
              },
              {
                "id": 140887430,
                "url": "https://finnhub.io/api/news?id=50fe240da8205292fac353b41a2e4a121dd417b1cab90129dc3c7f2770e48eb0",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "RBC Capital  analyst Shagun Singh   maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $100 to $110.",
                "category": "company",
                "datetime": 1783937734,
                "headline": "RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $110"
              },
              {
                "id": 140841554,
                "url": "https://finnhub.io/api/news?id=f808f463d5f0bb22dc96f28672fbc2e037f5d169cc4a1ef4e380aa09c200209e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The market is focused on today's costs, but the company has already sold a future that looks entirely different.",
                "category": "company",
                "datetime": 1783523487,
                "headline": "The One Number That Could Rewrite the Story for CoreWeave Stock"
              },
              {
                "id": 140840980,
                "url": "https://finnhub.io/api/news?id=f6b89872007a09af68ad6c31154624cb9a96d205fade79b74bd2350ac6679dce",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/08/Merck-Logo--Sign-At-Merck-Research-Labor.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Wall St analysts changed outlook on top names. KBW cut AON PT to $400, Barclay's cut T PT to $24, MS cut ROL PT to $65, GS cut SAM PT to $169, BofA raised ALLY PT to $53, Citi raised EW PT to $110, Wells Fargo raised MRK PT to $150, Jefferies raised ENVA PT.",
                "category": "company",
                "datetime": 1783500020,
                "headline": "Merck To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday"
              },
              {
                "id": 140844806,
                "url": "https://finnhub.io/api/news?id=e38a7c2046c3ef3ec12c87a213c329f67f1639c81b63531e57a13e266418537b",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Citigroup  analyst Joanne Wuensch   maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $101 to $110.",
                "category": "company",
                "datetime": 1783493221,
                "headline": "Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $110"
              },
              {
                "id": 140825083,
                "url": "https://finnhub.io/api/news?id=d4831a06a8b6f7f3feb8ad73f380bfa82b004b8eec49a45e787a5b8408bd3d1d",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $93 to $100.",
                "category": "company",
                "datetime": 1783339812,
                "headline": "Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100"
              },
              {
                "id": 140785971,
                "url": "https://finnhub.io/api/news?id=9417d92376a940320b0658b48d238996e548963863d2897c4d2a6cdaa04c2ccb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences is scheduled to report its second-quarter results soon, and analysts expect a single-digit earnings rise.",
                "category": "company",
                "datetime": 1782923534,
                "headline": "What You Need To Know Ahead of Edwards Lifesciences' Earnings Release"
              },
              {
                "id": 140772402,
                "url": "https://finnhub.io/api/news?id=29928c6dad2caaf8f5b48d7ed19e8c0bf20103ebebf8dcb587da59e9c1cee1d6",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Orlando--Fl--Usa---January-20--2022-Dard.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Wall Street analysts changed outlook on top names. Wedbush raised Replimune's price target, Canaccord cut Strategy's target, Barclays upgraded Watts Water, Rosenblatt boosted Comcast, Goldman increased State Street, Evercore raised Owens Corning, Cantor Fitzgerald boosted BioCryst Pharma, BTIG raised Edwards Lifesciences.",
                "category": "company",
                "datetime": 1782810296,
                "headline": "Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday"
              },
              {
                "id": 140774055,
                "url": "https://finnhub.io/api/news?id=67d042810efc8c2c01c9cd0720b35451092be688f1c6d77f410c83941db8fe06",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "BTIG  analyst Marie Thibault   maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $110.",
                "category": "company",
                "datetime": 1782806186,
                "headline": "BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110"
              },
              {
                "id": 140768835,
                "url": "https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...",
                "category": "company",
                "datetime": 1782778531,
                "headline": "Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"
              },
              {
                "id": 140765508,
                "url": "https://finnhub.io/api/news?id=114499e6dd4eaa6ca7fb68293857493880ef5d632bdbecc410078617b2bb4682",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.",
                "category": "company",
                "datetime": 1782754560,
                "headline": "Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?"
              },
              {
                "id": 140764119,
                "url": "https://finnhub.io/api/news?id=2558ab0870b5c4bd52b22a6d7cbb6ec5c9eb3d3645adb5a45d03774f7d39dc10",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences (EW) can sustain a high revenue growth rate given its technological leadership",
                "category": "company",
                "datetime": 1782750579,
                "headline": "Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says"
              },
              {
                "id": 140764120,
                "url": "https://finnhub.io/api/news?id=15115c8ddf386bc50ddc3fb9d01795b6c1cbd80a889b327a585df6d4ea69da48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.",
                "category": "company",
                "datetime": 1782731798,
                "headline": "Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic"
              },
              {
                "id": 140736627,
                "url": "https://finnhub.io/api/news?id=617247ab6b79fad40362b749ec64c44ac950f3493e24f2fb8d960847fa1cdeb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "NEW YORK, June 26, 2026--Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and innovating for patients. These new data – spanning aortic, mitral and tricuspid therapies – provide further understanding of the complexity of structural heart disease and the need for innovative treatment options.",
                "category": "company",
                "datetime": 1782483300,
                "headline": "Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves"
              },
              {
                "id": 140712255,
                "url": "https://finnhub.io/api/news?id=a9a0f050cff8fd433fe6026943b71c8fdff53264da5ddef0fa11d04499e6f753",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced the appointment of Ramin Mousavi as Chairman of the Board, effective immediately.",
                "category": "company",
                "datetime": 1782295260,
                "headline": "CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 2,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 30,
            "discarded_article_count": 28
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 12.5,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.6,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.6,
            "vcp_reason": "跌縮量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 2,
              "vol_ref": 4815046.033333333,
              "down_days": 7,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 4987838.1,
              "avg_vol_20": 4996479.05,
              "avg_vol_30": 4815046.033333333,
              "range_pct_10": 0.11999999999999997,
              "range_pct_20": 0.1566567164179105,
              "range_pct_30": 0.1566567164179105,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0358858597551241,
              "dist_to_20d_high": 0.13023159206563512,
              "down_shrink_days": 3,
              "breakout_level_20d": 96.29,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.766006097560975
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.690865671641791,
              "turnoverUsdM": 470.56051375,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.EW",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 79.2428,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 5.4,
            "take_profit_price": 88.7455,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 6
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.381731343283582,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 2.2536,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.69
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -138.99
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1414
    },
    "kdj": {
      "d": 15.24,
      "j": 1.44,
      "k": 10.64,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 23.51
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -3086314,
      "recentSlope": -3463611.4,
      "previousSlope": 1553270
    },
    "rsi": 14.93,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 91.133,
      "position": "SAR喺價上",
      "distancePct": 8.82,
      "previousTrend": "下降"
    },
    "ma50": 87.195,
    "macd": {
      "macd": -0.9097657201208733,
      "trend": "看跌",
      "signal": 0.21098410130969109,
      "histogram": -1.1207498214305645
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 89.6231,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.11,
      "score": 6,
      "avgVolume": 5051826,
      "currentVolume": 5618633
    },
    "derived": {
      "ma20": 89.8035,
      "ma50": 87.195,
      "prevClose": 84.37,
      "avgVolume10": 4991831,
      "avgVolume20": 5051826,
      "changePercent": -0.73,
      "avgVolumeForScore": 5051826
    },
    "ma_cross": {
      "ma20": 89.8035,
      "ma50": 87.195,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 90.099,
      "prevMa50": 87.0634,
      "spreadPct": 2.99,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 82.6821,
      "upper": 96.9249,
      "position": "中間"
    },
    "rsi_short": 12.23,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.11
    }
  }
}

{
  "close": 83.75,
  "volume": 5618633,
  "changePercent": -0.73
}